Type-I interferon receptor expression: its circadian rhythm and downregulation after interferon-alpha administration in peripheral blood cells from renal cancer patients

Int J Urol. 2009 Apr;16(4):356-9. doi: 10.1111/j.1442-2042.2009.02265.x. Epub 2009 Mar 18.

Abstract

Objectives: To investigate the regulation of interferon-alpha (IFN-alpha) receptor expression in metastatic renal cell carcinoma (RCC) after IFN-alpha administration.

Methods: Blood sampling was carried out in eight patients with metastatic RCC and six healthy volunteers. Flow-cytometric analysis using a monoclonal antibody against the active subunit of the type-I IFN-alpha receptor (IFNAR2) was carried out to examine the circadian rhythm of IFNAR2 expression in peripheral blood mononuclear cells (PBMC) as well as its downregulation after IFN-alpha administration.

Results: According to its circadian rhythm IFNAR2 in PBMC had a peak expression at night. Once IFN-alpha is administered, IFNAR2 levels in PBMC showed downregulation within 48 h and recovered within another 48 h.

Conclusions: Our findings might support the establishment of an optimal schedule for IFN-alpha administration.

MeSH terms

  • Carcinoma, Renal Cell / blood*
  • Carcinoma, Renal Cell / drug therapy*
  • Circadian Rhythm*
  • Down-Regulation*
  • Humans
  • Immunologic Factors / pharmacology
  • Immunologic Factors / therapeutic use*
  • Interferon-alpha / pharmacology
  • Interferon-alpha / therapeutic use*
  • Kidney Neoplasms / blood*
  • Kidney Neoplasms / drug therapy*
  • Leukocytes, Mononuclear / drug effects
  • Leukocytes, Mononuclear / metabolism*
  • Receptor, Interferon alpha-beta / biosynthesis*
  • Receptor, Interferon alpha-beta / drug effects

Substances

  • IFNAR2 protein, human
  • Immunologic Factors
  • Interferon-alpha
  • Receptor, Interferon alpha-beta